GREGG VALETA A 4
4 · BIOTIME INC · Filed May 14, 2010
Insider Transaction Report
Form 4
BIOTIME INCBTIM
GREGG VALETA A
Director
Transactions
- Sale
Common Shares, no par value
2010-05-12$7.79/sh−900$7,011→ 3,802 total - Sale
Common Shares, no par value
2010-05-12$7.76/sh−1,601$12,424→ 2,201 total - Sale
Common Shares, no par value
2010-05-12$7.75/sh−2,201$17,058→ 0 total - Exercise/Conversion
Common Shares, no par value
2010-05-12$3.45/sh+5,702$19,672→ 5,702 total - Sale
Common Shares, no par value
2010-05-12$7.78/sh−600$4,668→ 5,102 total - Sale
Common Shares, no par value
2010-05-12$7.80/sh−400$3,120→ 4,702 total - Exercise/Conversion
Option to Purchase Common Shares
2010-05-12−5,702→ 4,298 totalExercise: $3.45From: 2009-08-11Exp: 2014-08-10→ Common Shares (4,298 underlying)
Holdings
- 20,000
Option to Purchase Common Shares
Exercise: $2.30Exp: 2014-07-01→ Common Shares (20,000 underlying) - 10,000
Option to Purchase Common Shares
Exercise: $0.44Exp: 2013-04-30→ Common Shares (10,000 underlying)
Footnotes (3)
- [F1]Does not include shares that may be acquired upon the exercise of certain stock options.
- [F2]5,000 options became exercisable on September 30, 2009; December 31, 2009; and March 31, 2010. The remaining 5,000 options will become exercisable in a final quarterly installment on June 30, 2010.
- [F3]Became exercisable on May 1, 2008 and in 3 equal quarterly installments thereafter.